Search Result "MARK1"
MARK1 is a Novel Target for miR-125a-5p: Implications for Cell Migration in Cervical Tumor Cells
Journal: MicroRNA
Volume: 7 Issue: 1 Year: 2018 Page: 54-61
Author(s): MartÃnez-Acuna Natalia,Gonzalez-Torres Alejandro,Tapia-Vieyra Juana Virginia,Luis Marat Alvarez-Salas
Primate-Accelerated Evolutionary Genes: Novel Routes to Drug Discovery in Psychiatric Disorders
Journal: Current Medicinal Chemistry
Volume: 17 Issue: 1 Year: 2010 Page: 1300-1316
Author(s): J. -M. Moalic, Y. Le Strat, A. -M. Lepagnol-Bestel, N. Ramoz, Y. Loe-Mie, G. Maussion, P. Gorwood, M. Simonneau
Safety Profile of the Newest Antiepileptic Drugs: A Curated Literature Review
Journal: Current Pharmaceutical Design
Volume: 23 Issue: 37 Year: 2017 Page: 5606-5624
Author(s): Caterina Palleria,Giuseppe Cozza,Rajeshree Khengar,Vincenzo Libri,Giovambattista De Sarro
The Canonical Wnt Signaling Pathway in Autism
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 13 Issue: 5 Year: 2014 Page: 765-770
Author(s): Yinghua Zhang,Xiangshan Yuan,Zhongping Wang,Ruixi Li
Targeting Kinase Interaction Networks: A New Paradigm in PPI Based Design of Kinase Inhibitors
Journal: Current Topics in Medicinal Chemistry
Volume: 19 Issue: 6 Year: 2019 Page: 467-485
Author(s): Pranitha Jenardhanan,Manivel Panneerselvam,Premendu P. Mathur
Targeting Tau Hyperphosphorylation via Kinase Inhibition: Strategy to Address Alzheimer's Disease
Journal: Current Topics in Medicinal Chemistry
Volume: 20 Issue: 12 Year: 2020 Page: 1059-1073
Author(s): Ahmad Abu Turab Naqvi,Gulam Mustafa Hasan,Md. Imtaiyaz Hassan
Death-Associated Protein Kinase 1 as a Promising Drug Target in Cancer and Alzheimerâs Disease
Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 14 Issue: 2 Year: 2019 Page: 144-157
Author(s): Dongmei Chen,Xiao Z. Zhou,Tae H. Lee
An Arylidene-Thiazolidinedione Derivative, GPU-4, without PPARγ Activation, Reduces Retinal Neovascularization
Journal: Current Neurovascular Research
Volume: 8 Issue: 1 Year: 2011 Page: 25-34
Author(s): Shinsuke Nakamura, Kei Hayashi, Haruka Takizawa, Tetsuji Murase, Kazuhiro Tsuruma, Masamitsu Shimazawa, Hiroki Kakuta, Hideko Nagasawa, Hideaki Hara
LRRK2 Kinase Inhibition as a Therapeutic Strategy for Parkinsonâs Disease, Where Do We Stand?
Journal: Current Neuropharmacology
Volume: 14 Issue: 3 Year: 2016 Page: 214-225
Author(s): Jean-Marc Taymans,Elisa Greggio
A Novel Multi-Target Drug Screening Strategy Directed Against Key Proteins of DAPk Family
Journal: Combinatorial Chemistry & High Throughput Screening
Volume: 16 Issue: 6 Year: 2013 Page: 449-457
Author(s): Syam B. Nair, Shaik M. Fayaz, Golgodu K. Rajanikant